Suicidality associated with antiepileptic drugs: Implications for the treatment of neuropathic pain and fibromyalgia

Pain

Volumn 154, Issue 3, 2013, Pages 345-349

  Pereira, Anthony ^a   Gitlin, Michael J ^b   Gross, Robert A ^a   Posner, Kelly ^c   Dworkin, Robert H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

BIPOLAR DISORDER; DATA BASE; DEPRESSION; EPILEPSY; FIBROMYALGIA; HUMAN; MAJOR DEPRESSION; MIGRAINE; NEUROPATHIC PAIN; PRIORITY JOURNAL; REVIEW; SUICIDAL BEHAVIOR; TREATMENT INDICATION;

EID: 84874515225     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2012.12.024     Document Type: Review

References (40)

1. F. Andersohn, R. Schade, S.N. Willich, and E. Garbe Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior Neurology 75 2010 335 340
2. A. Arana, C.E. Wentworth, J.L. Ayuso-Mateos, and F.M. Arellano Suicide-related events in patients treated with antiepileptic drugs New Engl J Med 363 2010 542 551
3. N. Attal, G. Cruccu, R. Baron, M. Haanpää, P. Hansson, T.S. Jensen, and T. Nurmikko EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur J Neurol 17 2010 1113 1123
4. M. Bagary Epilepsy, antiepileptic drugs and suicidality Curr Opin Neurol 24 2011 177 182
5. M.J. Bair, R.L. Robinson, W. Katon, and K. Kroenke Depression and pain comorbidity: a literature review Arch Intern Med 163 2003 2433 2445
6. C.L. Bowden, J.R. Calabrese, G. Sachs, L.N. Yatham, S.A. Asghar, M. Hompland, P. Montgomery, N. Earl, and T.M. Smoot Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Arch Gen Psychiatry 60 2003 392 400
7. V. Bril, J. England, G.M. Franklin, M. Backonja, J. Cohen, D. Del Toro, E. Feldman, D.J. Iverson, B. Perkins, J.W. Russell, and D. Zochodne Evidence-based guideline: treatment of painful diabetic neuropathy Neurology 76 2011 1758 1765
8. S.F. Carville, S. Arendt-Nielsen, H. Bliddal, F. Blotman, J.C. Branco, D. Buskila, J.A. Da Silva, B. Danneskiold-Samsoe, F. Dincer, C. Henriksson, K.G. Henriksson, E. Kosek, K. Longley, G.M. McCarthy, S. Perrot, M. Puszczewicz, P. Sarzi-Puttini, A. Silman, M. Spath, and E.H. Choy EULAR evidence-based recommendations for the management of fibromyalgia syndrome Ann Rheum Dis 67 2008 536 541
9. Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control. Suicide: risk and protective factors. Available from: < http://www.cdc.gov/ViolencePrevention/suicide/riskprotectivefactors. html >; August 2010 [accessed 31.12.11].
10. J. Christensen, M. Vestergaard, P. Mortensen, P. Sidenius, and E. Agerbo Epilepsy and risk of suicide: a population-based case-control study Lancet Neurol 6 2007 693 698
11. R.H. Dworkin, A.B. O'Connor, J. Audette, R. Baron, G.K. Gourlay, M.L. Haanpää, J.L. Kent, E.J. Krane, A.A. Lebel, R.M. Levy, S.C. Mackey, J. Mayer, C. Miaskowski, S.N. Raja, A.S. Rice, K.E. Schmader, B. Stacey, S. Stanos, R.D. Treede, D.C. Turk, G.A. Walco, and C.D. Wells Recommendations for the pharmacological management of neuropathic pain: an overview and literature update Mayo Clin Proc 85 2010 S3 S14
12. R.H. Dworkin, A.B. O'Connor, M. Backonja, J.T. Farrar, T.S. Jensen, E.A. Kalso, J.D. Loeser, C. Miaskowski, T.J. Nurmikko, R.K. Portenoy, A.S.C. Rice, B.R. Stacey, R.-D. Treede, D.C. Turk, and M.S. Wallace Pharmacologic management of neuropathic pain: evidence-based recommendations PAIN® 132 2007 237 251
13. S. Evers, J. Afra, A. Frese, P.J. Goadsby, M. Linde, A. May, and P.S. Sandor EFNS guideline on the drug treatment of migraine: revised report of an EFNS task force Eur J Neurol 16 2009 968 981
14. J.R. Geddes, J.R. Calabrese, and G.M. Goodwin Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials Br J Psychiatry 194 2009 4 9
15. R.D. Gibbons, K. Hur, C.H. Brown, and J.J. Mann Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder Arch Gen Psychiatry 66 2009 1354 1360
16. R.D. Gibbons, K. Hur, C.H. Brown, and J.J. Mann Gabapentin and suicide attempts Pharmacoepidemiol Drug Saf 19 2010 1241 1247
17. T.A. Hammad, T. Laughren, and J. Racoosin Suicidality in pediatric patients treated with antidepressant drugs Arch Gen Psychiatry 63 2006 332 339
18. D.C. Hesdorffer, and A.M. Kanner The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia 50 2009 978 986
19. T. Ingenhoven, P. Lafay, T. Rinne, J. Passchier, and H. Duivenvoorden Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials J Clin Psychiatry 71 2010 14 25
20. J.E. Jones, B.P. Hermann, J.J. Barry, F.G. Gilliam, A.M. Kanner, and K.J. Meador Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy Epilepsy Behav 4 2003 531 538
21. K. Lieb, B. Völlm, C. Rücker, A. Timmer, and J.M. Stoffers Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials Br J Psychiatry 196 2010 4 12
22. Medicines and Healthcare Products Regulatory Agency. Drug safety update: latest advice for all medicines users. 2008;2:2. Available from: < http://www.mhra.gov.uk/home/groups/pl-p/documents/publication/con023077.pdf >; [accessed 10.02.12].
23. R.E. Meyer, C. Salzman, E.A. Youngstrom, P.J. Clayton, F.K. Goodwin, J.J. Mann, L.D. Alphs, K. Broich, W.K. Goodman, J.F. Greden, H.Y. Meltzer, S.L.T. Normand, K. Posner, D. Shaffer, M.A. Oquendo, B. Stanley, M.H. Trivedi, G. Turecki, C.M. Beasley Jr., A.L. Beautrais, J.A. Bridge, G.K. Brown, D.A. Revicki, N.D. Ryan, and D.V. Sheehan Suicidality and risk of suicide: definition, drug safety concerns, and a necessary target for drug development: a brief report J Clin Psychiatry 71 2010 1040 1046
24. R.E. Meyer, C. Salzman, E.A. Youngstrom, P.J. Clayton, F.K. Goodwin, J.J. Mann, L.D. Alphs, K. Broich, W.K. Goodman, J.F. Greden, H.Y. Meltzer, S.L.T. Normand, K. Posner, D. Shaffer, M.A. Oquendo, B. Stanley, M.H. Trivedi, G. Turecki, C.M. Beasley Jr., A.L. Beautrais, J.A. Bridge, G.K. Brown, D.A. Revicki, N.D. Ryan, and D.V. Sheehan Suicidality and risk of suicide: definition, drug safety concerns, and a necessary target for drug development: a consensus statement J Clin Psychiatry 71 2010 e1 e21
25. D.E. Moulin, A.J. Clark, I. Gilron, M.A. Ware, C.P. Watson, B.J. Sessle, T. Coderre, P.K. Morley-Forster, J. Stinson, A. Boulanger, P. Peng, G.A. Finley, P. Taenzer, P. Squire, D. Dion, A. Cholkan, A. Gilani, A. Gordon, J. Henry, R. Jovey, M. Lynch, A. Mailis-Gagnon, A. Panju, G.B. Rollman, and A. Velly Pharmacological management of chronic neuropathic pain: consensus statement and guidelines from the Canadian Pain Society Pain Res Manag 12 2007 13 21
26. M. Mula, and J.W. Sander Negative effects of antiepileptic drugs on mood in patients with epilepsy Drug Saf 30 2007 555 567
27. National Prescribing Centre. EMEA recommends updating antiepileptic product information with warnings on suicidal risk. Available from: < http://www.npc.nhs.uk/rapidreview/?p=268 >; January 30, 2009 [accessed 01.01.12].
28. J.B. Olesen, P.R. Hansen, J. Erdal, S.Z. Abildstrom, P. Weeke, E.L. Fosbol, H.E. Poulsen, and G.H. Gislason Antiepileptic drugs and risk of suicide: a nationwide study Pharmacoepidemiol Drug Saf 19 2010 518 524
29. E. Patorno, R.L. Bohn, P.M. Wahl, J. Avorn, A.R. Patrick, J. Liu, and S. Schneeweiss Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death JAMA 303 2010 1401 1409
30. K. Posner, G.K. Brown, B. Stanley, D.A. Brent, K.V. Yershova, M.A. Oquendo, G.W. Currier, G.A. Melvin, L. Greenhill, S. Shen, and J.J. Mann The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults Am J Psychiatry 168 2011 1266 1277
31. K. Posner, M.A. Oquendo, M. Gould, B. Stanley, and M. Davies Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants Am J Psychiatry 164 2007 1035 1043
32. G.E. Ratcliffe, M.W. Enns, S.L. Belik, and J. Sareen Chronic pain conditions and suicidal ideation and suicide attempts: an epidemiologic perspective Clin J Pain 24 2008 204 210
33. Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of headache in adults: national clinical guideline (SIGN publication no. 107). Edinburgh: Scottish Intercollegiate Guidelines Network; 2008.
34. M.T. Smith, R.R. Edwards, R.C. Robinson, and R.H. Dworkin Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased risk PAIN® 111 2004 201 208
35. M. Stone, T. Laughren, M.L. Jones, M. Levenson, P.C. Holland, A. Hughes, T.A. Hammad, R. Temple, and G. Rochester Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration BMJ 339 2009 b2880
36. N.K. Tang, and C. Crane Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links Psychol Med 36 2006 575 586
37. US Food and Drug Administration. Statistical review and evaluation: antiepileptic drugs and suicidality. Available from: < http://www.fda.gov/ ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf >; May 2008 [accessed 16.08.12].
38. US Food and Drug Administration. Guidance for industry: suicidal ideation and behavior: prospective assessment of occurrence in clinical trials. Available from: < http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm225130.pdf >; August 2012 [accessed 16.08.12].
39. A.C. VanCott, J.A. Cramer, L.A. Copeland, J.E. Zeber, M.A. Steinman, J.J. Dersh, M.E. Glickman, E.M. Mortensen, M.E. Amuan, and M.J. Pugh Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system BMC Med 8 2010 4
40. X. Wen, K.J. Meador, D.W. Loring, S. Eisenschenk, R. Segal, and A.G. Hartzema Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy? Epilepsy Behav 19 2010 494 500